Moderna Inc
Inventory futures rise following Fed decides to keep premiums continual: Live updates
Stock futures advanced Wednesday evening as buyers appeared ahead to far more corporate earnings due Thursday and important labor information established for afterwards in the week. Dow Jones Industrial Common futures added 65 details, or .2%. S&P 500 futures climbed .2%. Nasdaq 100 futures improved by .3%. In immediately after-several hours investing, chipmaker Qualcomm rose […]
Read More
Get prepared traders: These shares are predicted to have the greatest moves on earnings this week
As the occupied 1st-quarter period moves alongside, a number of shares continue to established to report could be because of for big swings. Initially-quarter earnings have boosted stocks this 7 days, as a lot more than 77% companies in the S & P 500 have exceeded analysts’ anticipations, according to FactSet. The S & P […]
Read More
Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales
Exterior view of the entrance to Merck headquarters on February 05, 2024 in Rahway, New Jersey. Spencer Platt | Getty Images Merck on Thursday reported first-quarter revenue and adjusted earnings that topped expectations as it posted strong sales of its blockbuster cancer drug Keytruda and vaccine products. The pharmaceutical giant also raised and narrowed its […]
Read More
Moderna halts plans to build Kenya vaccine plant as Covid shot demand plunges
A nurse prepares a dose of Moderna Covid-19 vaccine at Oltepesi Dispensary in Kajiado, Kenya, on September 9, 2021. Patrick Meinhardt | AFP | Getty Images Moderna on Thursday said it has paused plans to build a vaccine-manufacturing site in Kenya after a steep drop in demand for its Covid vaccines. The biotech company said […]
Read More
Stocks making the greatest moves midday: Boeing, Norfolk Southern, Nvidia & more
Check out out the corporations earning headlines in midday investing. BlackBerry — BlackBerry shares popped more than 9% immediately after the business announced a partnership with Sophisticated Micro Equipment on robotics programs. Moderna — The vaccine maker received 6%. Reuters claimed that Moderna’s most cancers drug it is performing on with Merck confirmed promising results […]
Read More
Shares producing the biggest moves midday: GameStop, Merck, Carnival, Cintas and far more
Verify out the firms creating headlines in midday trading. GameStop — GameStop shed 15% following the video recreation retailer claimed decreased fourth-quarter income from a yr ago. The corporation also stated it axed an unspecified amount of roles to trim expenditures. Merck — Merck jumped 5% immediately after the U.S. Foodstuff and Drug Administration on […]
Read More
Stocks earning the greatest moves premarket: Robinhood, GameStop, Merck and additional
Look at out the firms building headlines in premarket investing. Robinhood — Shares of the brokerage business jumped additional than 6% immediately after unveiling its Robinhood Gold Card, a credit rating card wherever funds again can be deposited into a brokerage account. Concentrix — Shares slipped approximately 4% on the back of disappointing fiscal second-quarter […]
Read More
Moderna moves three vaccines into final stage trials as it works to rebound from Covid slump
Nikos Pekiaridis | Lightrocket | Getty Images Moderna has more to offer beyond its Covid vaccine. The biotech company made that clear on Wednesday, announcing positive clinical trial data on three experimental vaccines for other diseases. The company is moving those shots to final stage studies, it said. The update brings Moderna a step closer […]
Read More
Moderna says new Covid vaccine showed stronger immune response than current shot in study
A nurse fills a syringe with Moderna Covid-19 vaccine. Fred Tanneau | Afp | Getty Images Moderna on Tuesday said a new version of its Covid vaccine triggered a stronger immune response against the virus than its current shot in a late-stage trial. The results come as Moderna competes with rival Pfizer for more share […]
Read More
Pfizer RSV vaccine maintains protection in older adults over two seasons in trial
Respiratory syncytial virus vial. Manjurul | Istock | Getty Images Pfizer‘s vaccine against respiratory syncytial virus maintained protection for older adults across two full seasons of the disease in an ongoing late-stage clinical trial, the company announced Thursday. The shot’s efficacy declined slightly compared with the levels of protection after one RSV season, but the […]
Read More